Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clinical mastitis ain't what it used to be
Pam Ruegg
Professor Pam Ruegg speaking at BCVA Congress.
BCVA vets encouraged to keep ahead of the curve on intramammary therapy

"Mastitis today ain't your grandfather's mastitis!" said Professor Pam Ruegg from Wisconsin at the beginning of her presentation entitled 'Treatment of clinical mastitis in lactating cows: new bugs, old drugs and changing expectations' at the BCVA Congress in Hinckley.

Shifting patterns of pathogens during the past few decades mean that current control programmes using intramammary antibiotics may not match the reality of cases on farm. So, for instance, Strep agalactiae infections are now very rare, and the treatment of Staph aureus is a minor aspect of its control.  

The difficulty is that the occurrence of mastitis is based on detection of inflammation not infection. Twenty-five to 40 per cent of cases are culture negative because the cow's immune system has already dealt with the pathogen.

Few mastitis cases are medical emergencies. With this in mind, it is a good idea to encourage farmers to use a simple three-point case assessment score. On average, 85 per cent of cases can be left until a full assessment has been made of the clinical history of the affected cow and bacterial culture. Most of the 'mild' cases are on the way to getting better anyway and there may be benefits to delaying  intramammary infusion and embarking on proper assessment of the cow.

"So can we justify the treatments we use?" asked Prof Ruegg. "The data suggest that in some cases the answer might be 'no'. There is an opportunity to improve our approach. Treatment of cases should be based on the aetiology of the infection and to do this it is useful to have 'on-farm' culture facilities."

Concluding her presentation, Prof Ruegg offered six "take home" points to delegates:

1. Before treatment, check the medical history of the cow. Is she in third lactation or more? There is no evidence that chronic mastitis responds to multiple antibiotic treatments, and in many cases, the milk will return to normal appearance

2. Extended intramammary therapy should be applied to specific cases – only where there is evidence of infection deep in mammary tissue

3. Do not administer antibiotics to cows that do not need it

4. On many farms the use of antibiotics to treat cows with mild E. coli mastitis isn't necessary

5. Develop protocols and monitoring controls

6. Remember, simple symptoms of inflammation do not indicate that antibiotic therapy is necessary. We are always behind the curve and the cow is already trying to cure the infection by the time we see the changes in the milk.

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.